30 Day Trial


Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.


  • 9:30 a.m. Orthofix entered into a definitive agreement to acquire Spinal Kinetics for US $45MM in cash plus up to $60MM in potential milestone payments. The transaction is expected to close in 2Q18.
  • 4:15 p.m. OrthoPediatrics posted 4Q17 revenue of US $11.7MM, +23.7% vs. 4Q16, and 2017 revenue of $45.6MM, +22.4% vs. 2016.
  • DJO Global posted 4Q17 revenue of US $312.2MM, +5.3% vs. 4Q16, and 2017 revenue of $1,186.1MM, +2.7% vs. 2016.
Read More

Articles of Interest All Articles

Surgeon Touts Benefits of Molybdenum-Rhenium in Spinal Applications

Kornelis Poelstra, M.D., Ph.D., believes that new materials will bring the next wave of innovation in spine. His belief spurred him to send FDA a letter asking for a list of acceptable materials to study in animals with the intent of future commercialization. It also spurred a partnership when he crossed paths with Jay Yadav, M.D., an entrepreneurial cardiologist working to introduce molybdenum-rhenium (MoRe) to orthopaedics. 

We spoke with him to gain further understanding of this alloy.